XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Investments in equity securities
3 Months Ended
Mar. 31, 2023
Investments Debt And Equity Securities [Abstract]  
Investments in equity securities

Note 5. Investments in equity securities

Investments in equity securities as of March 31, 2023 and December 31, 2022 are summarized as follows (in millions).

 

 

 

Cost Basis

 

 

Net Unrealized
Gains

 

 

Fair Value

 

March 31, 2023*

 

 

 

 

 

 

 

 

 

Banks, insurance and finance

 

$

24,023

 

 

$

41,292

 

 

$

65,315

 

Consumer products

 

 

40,003

 

 

 

144,506

 

 

 

184,509

 

Commercial, industrial and other

 

 

57,316

 

 

 

21,021

 

 

 

78,337

 

 

$

121,342

 

 

$

206,819

 

 

$

328,161

 

 

——————

* Approximately 77% of the aggregate fair value was concentrated in five companies (American Express Company – $25.0 billion; Apple Inc. – $151.0 billion; Bank of America Corporation – $29.5 billion; The Coca-Cola Company – $24.8 billion and Chevron Corporation – $21.6 billion).

 

 

 

Cost Basis

 

 

Net Unrealized
Gains

 

 

Fair Value

 

December 31, 2022*

 

 

 

 

 

 

 

 

 

Banks, insurance and finance

 

$

25,893

 

 

$

43,663

 

 

$

69,556

 

Consumer products

 

 

40,508

 

 

 

112,384

 

 

 

152,892

 

Commercial, industrial and other

 

 

65,209

 

 

 

21,136

 

 

 

86,345

 

 

$

131,610

 

 

$

177,183

 

 

$

308,793

 

 

——————

* Approximately 75% of the aggregate fair value was concentrated in five companies (American Express Company – $22.4 billion; Apple Inc. – $119.0 billion; Bank of America Corporation – $34.2 billion; The Coca-Cola Company – $25.4 billion and Chevron Corporation – $30.0 billion).

Notes to Consolidated Financial Statements (Continued)

Note 5. Investments in equity securities (Continued)

During 2022, we began to acquire common stock of Occidental Petroleum Corporation (“Occidental”). Our aggregate voting interest in Occidental exceeded 20% on August 4, 2022 and we adopted the equity method as of that date. See Note 6. We report our investments in Occidental Cumulative Perpetual Preferred Stock and Occidental common stock warrants at fair value as equity securities, as such interests are not in-substance common stock under GAAP and are not eligible for the equity method.

As of March 31, 2023, our investment in Occidental preferred stock had an aggregate liquidation value of approximately $9.5 billion. During March of 2023, Occidental issued mandatory redemption notifications at a price of 110% of the liquidation value, plus accrued and unpaid dividends for $474 million of preferred stock liquidation value due to excess distributions by Occidental to its common stockholders, as defined under the agreement. The preferred stock accrues dividends at 8% per annum and is redeemable at the option of Occidental commencing in 2029 at a redemption price equal to 105% of the liquidation preference, plus any accumulated and unpaid dividends. Our investment in Occidental warrants allows us to purchase up to 83.86 million shares of Occidental common stock at an exercise price of $59.62 per share. The warrants are exercisable in whole or in part until one year after the redemption of the preferred stock.

As of March 31, 2023, we owned 151.6 million shares of American Express Company (“American Express”) common stock representing 20.4% of the American Express outstanding common stock. Since 1995, we have been party to an agreement with American Express whereby we agreed to vote a significant portion of our shares in accordance with the recommendations of the American Express Board of Directors. We have also agreed to passivity commitments as requested by the Board of Governors of the Federal Reserve System, which collectively, in our judgment, restrict our ability to exercise significant influence over the operating and financial policies of American Express. Accordingly, we do not use the equity method with respect to our investment in American Express common stock and we continue to record our investment at fair value.